Get started
Author

Urwah Noor

Observed name: Noor, Urwah
ORCID: 0009-0007-3885-5898
Observed ORCID: 0009-0007-3885-5898
OpenAlex ID: A5017612596
Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
2022 · Eleanor L Watts, Aurora Perez-Cornago, et al. · International Journal of Epidemiology · 60
PDF
Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia
2022 · Eleanor L. Watts, Aurora Perez‐Cornago, et al. · International Journal of Cancer · 50
PDF
Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries
2023 · Tammy Y. N. Tong, Robert Clarke, et al. · European Journal of Nutrition · 8
PDF
Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case–control sets from the European Prospective Investigation into Cancer and Nutrition
2024 · Zoe S. Grenville, Urwah Noor, et al. · International Journal of Cancer · 5
PDF
Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al. · Cancer Epidemiology Biomarkers & Prevention · 4
Diet and BMI Correlate with Metabolite Patterns Associated with Aggressive Prostate Cancer
2022 · Zoe S. Grenville, Urwah Noor, et al. · Nutrients · 4
MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
2026 · Max Schlaak, Carolina Cimminiello, et al. · Clinical Cancer Research · 2
PDF
Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition
2024 · Tuck Seng Cheng, Urwah Noor, et al. · BMC Cancer · 2
PDF
Prediagnostic circulating 25-hydroxyvitamin D and prostate cancer-specific survival: a collaborative pooled analysis of 13 prospective studies
2026 · Jiaqi Huang, Aurora Perez-Cornago, et al. · BMC Medicine
Tables S1-S10 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
2026 · Max Schlaak, Carolina Cimminiello, et al.
Figures S1-S11 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
2026 · Max Schlaak, Carolina Cimminiello, et al.
Supplementary Methods 1 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
2026 · Max Schlaak, Carolina Cimminiello, et al.
Data from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
2026 · Max Schlaak, Carolina Cimminiello, et al.
Evaluation of the 4Kscore in EPIC: Reply
2026 · Karl Smith-Byrne, Georgina K. Fensom, et al. · Cancer Epidemiology Biomarkers & Prevention
Supplementary Table 4 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Supplementary Table 2 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Supplementary Table 1 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Data from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Supplementary Table 3 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Table 1 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Table 3 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Table 4 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Table 2 from Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
2025 · K. Smith-Byrne, Georgina K. Fensom, et al.
Empowering women: urging immediate breast reconstruction awareness in Pakistan
2025 · Urwah Noor, Muhammad Shumas · Journal of the Pakistan Medical Association
PDF
Works count: 26
Citation count: 134
H-index: 4
I10-index: 2
Year
Topic
Type